About Advalytix AG
Advalytix AG is a Healthcare company based in Munchen (Germany) founded in 2000, and was acquired by Beckman Coulter in June 2009. It provides single cell molecular analysis, and the miniaturization of biological tests for RD.
Company details
Advalytix provides cell-based molecular diagnostics with main focus is the miniaturization of diagnostic and biological tests for RD. It was initially a Cipio Partner portfolio company and later from 2005 was a wholly owned subsidiary of Olympus Life and Material Science Europa. Its products link imaging technologies such as microscopy with nucleic acid analysis, enabling to offer turnkey system solutions consisting of both instruments and reagents. It was acquired by Beckman coulter in 2009 and is currently a team within Beckman Coulter Genomics.
- Headquarters Munchen, Germany
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website advalytix.com
- Social LinkedIn
- Acquired by Beckman Coulter (Jun 2009)
- Investors
- Acquired byBeckman Coulter
(Jun 2009)
Investors in Advalytix AG
Advalytix AG has secured backing from 1 investor. Prominent investors backing the company include Beckman Coulter.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Clinical diagnostic products are manufactured for biomedical testing. | 1935 | beckmancoulter.com | Brea, United States |
Investor details for Advalytix AG
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Advalytix AG
2 dated milestones of Advalytix AG across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Advalytix AG is founded.
- Exit Acquired by Beckman Coulter.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Advalytix AG
Advalytix AG was founded in 2000.
Advalytix AG is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Advalytix provides cell-based molecular diagnostics with main focus is the miniaturization of diagnostic and biological tests for RD. It was initially a Cipio Partner portfolio company and later from 2005 was a wholly owned subsidiary of Olympus Life and Material Science Europa. Its products link imaging technologies such as microscopy with nucleic acid analysis, enabling to offer turnkey system solutions consisting of both instruments and reagents. It was acquired by Beckman coulter in 2009 and is currently a team within Beckman Coulter Genomics.
Advalytix AG has 1 investor. Key investors include Beckman Coulter.
Yes. Advalytix AG was acquired by Beckman Coulter in June 2009.
